Investment Partners Asset Management Inc. Purchases New Stake in Intuitive Surgical, Inc. $ISRG

Investment Partners Asset Management Inc. purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 383 shares of the medical equipment provider’s stock, valued at approximately $208,000.

Several other large investors have also recently bought and sold shares of the business. True North Advisors LLC increased its position in Intuitive Surgical by 25.3% in the 2nd quarter. True North Advisors LLC now owns 2,186 shares of the medical equipment provider’s stock worth $1,188,000 after purchasing an additional 442 shares during the last quarter. Falcon Wealth Planning increased its position in Intuitive Surgical by 0.8% in the 2nd quarter. Falcon Wealth Planning now owns 5,775 shares of the medical equipment provider’s stock worth $3,138,000 after purchasing an additional 45 shares during the last quarter. Novem Group increased its position in Intuitive Surgical by 7.8% in the 2nd quarter. Novem Group now owns 845 shares of the medical equipment provider’s stock worth $459,000 after purchasing an additional 61 shares during the last quarter. Embree Financial Group acquired a new position in Intuitive Surgical in the 2nd quarter worth about $221,000. Finally, EdgeRock Capital LLC increased its position in Intuitive Surgical by 9.5% in the 2nd quarter. EdgeRock Capital LLC now owns 574 shares of the medical equipment provider’s stock worth $311,000 after purchasing an additional 50 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. This represents a 59.69% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Up 0.7%

Shares of NASDAQ:ISRG opened at $441.12 on Friday. The business has a 50 day moving average price of $469.43 and a 200 day moving average price of $501.46. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The company has a market cap of $158.13 billion, a price-to-earnings ratio of 61.52, a PEG ratio of 4.59 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the prior year, the company earned $1.78 EPS. The firm’s revenue for the quarter was up 21.4% compared to the same quarter last year. Analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Ratings Changes

Several research analysts have weighed in on the company. BTIG Research upped their target price on Intuitive Surgical from $566.00 to $571.00 and gave the stock a “buy” rating in a research report on Wednesday, July 23rd. Wells Fargo & Company upped their target price on Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Evercore ISI increased their price objective on Intuitive Surgical from $470.00 to $550.00 and gave the company an “in-line” rating in a report on Tuesday, July 8th. Finally, Royal Bank Of Canada reissued an “outperform” rating and set a $615.00 price objective on shares of Intuitive Surgical in a report on Tuesday, August 19th. Thirteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.